LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 114

Search options

  1. Article ; Online: The profile of cholesterol metabolism does not interfere with the cholesterol-lowering efficacy of phytostanol esters.

    Gylling, Helena / Öörni, Katariina / Nylund, Lotta / Wester, Ingmar / Simonen, Piia

    Clinical nutrition (Edinburgh, Scotland)

    2024  Volume 43, Issue 3, Page(s) 587–592

    Abstract: Background & aims: Increasing evidence suggests that high cholesterol absorption efficiency enhances the risk of atherosclerotic cardiovascular diseases. It is not known whether inhibiting cholesterol absorption has different metabolic effects in high- ... ...

    Abstract Background & aims: Increasing evidence suggests that high cholesterol absorption efficiency enhances the risk of atherosclerotic cardiovascular diseases. It is not known whether inhibiting cholesterol absorption has different metabolic effects in high- vs. low cholesterol absorbers. We evaluated the effects of phytostanol esters on serum lipids and cholesterol metabolism in a post hoc study of three randomized, double-blind, controlled trials. The participants were classified into low (n = 20) and high (n = 21) cholesterol absorbers by median cholesterol absorption efficiency based on the plasma cholesterol absorption marker cholestanol at baseline.
    Methods: The participants consumed mayonnaise or margarine without or with phytostanol esters for six to nine weeks without other changes in the diet or lifestyle. Serum cholesterol, cholestanol, lathosterol, and faecal neutral sterols and bile acids were analysed by gas-liquid chromatography. According to power calculations, the size of the study population (n = 41) was appropriate.
    Results: During the control period, cholesterol synthesis, and faecal neutral sterols and bile acids were lower in high- vs. low absorbers (p < 0.05 for all). Phytostanol esters reduced low-density lipoprotein cholesterol by 10-13% in both groups, and directly measured cholesterol absorption efficiency by 41 ± 7% in low- and 47 ± 5% in high absorbers (p < 0.001 for all) without side effects. Cholesterol synthesis and faecal neutral sterols (p < 0.01) increased in both groups, more markedly in the high vs. low absorbers (p < 0.01).
    Conclusions: Low cholesterol absorption combined with high faecal neutral sterol excretion are components of reverse cholesterol transport. Thus, high- vs. low absorbers had a more disadvantageous metabolic profile at baseline. In both groups, phytostanol esters induced favourable changes in serum, lipoprotein, and metabolic variables known to help in prevention of the development of atherosclerotic cardiovascular diseases.
    MeSH term(s) Humans ; Cardiovascular Diseases/prevention & control ; Cholesterol ; Sterols ; Phytosterols ; Atherosclerosis/prevention & control ; Bile Acids and Salts ; Cholestanols
    Chemical Substances Cholesterol (97C5T2UQ7J) ; Sterols ; Phytosterols ; Bile Acids and Salts ; Cholestanols
    Language English
    Publishing date 2024-01-20
    Publishing country England
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 604812-2
    ISSN 1532-1983 ; 0261-5614
    ISSN (online) 1532-1983
    ISSN 0261-5614
    DOI 10.1016/j.clnu.2024.01.022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Aggregation Susceptibility of Low-Density Lipoproteins-A Novel Modifiable Biomarker of Cardiovascular Risk.

    Öörni, Katariina / Kovanen, Petri T

    Journal of clinical medicine

    2021  Volume 10, Issue 8

    Abstract: Circulating low-density lipoprotein (LDL) particles enter the arterial intima where they bind to the extracellular matrix and become modified by lipases, proteases, and oxidizing enzymes and agents. The modified LDL particles aggregate and fuse into ... ...

    Abstract Circulating low-density lipoprotein (LDL) particles enter the arterial intima where they bind to the extracellular matrix and become modified by lipases, proteases, and oxidizing enzymes and agents. The modified LDL particles aggregate and fuse into larger matrix-bound lipid droplets and, upon generation of unesterified cholesterol, cholesterol crystals are also formed. Uptake of the aggregated/fused particles and cholesterol crystals by macrophages and smooth muscle cells induces their inflammatory activation and conversion into foam cells. In this review, we summarize the causes and consequences of LDL aggregation and describe the development and applications of an assay capable of determining the susceptibility of isolated LDL particles to aggregate when exposed to human recombinant sphingomyelinase enzyme ex vivo. Significant person-to-person differences in the aggregation susceptibility of LDL particles were observed, and such individual differences largely depended on particle lipid composition. The presence of aggregation-prone LDL in the circulation predicted future cardiovascular events in patients with atherosclerotic cardiovascular disease. We also discuss means capable of reducing LDL particles' aggregation susceptibility that could potentially inhibit LDL aggregation in the arterial wall. Whether reductions in LDL aggregation susceptibility are associated with attenuated atherogenesis and a reduced risk of atherosclerotic cardiovascular diseases remains to be studied.
    Language English
    Publishing date 2021-04-19
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm10081769
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Influence of sex and gender on the biology of atherosclerotic cardiovascular disease: Special issue.

    Osto, Elena / Roeters van Lennep, Jeanine E / Tokgözoğlu, Lale / Öörni, Katariina

    Atherosclerosis

    2023  Volume 384, Page(s) 117297

    MeSH term(s) Male ; Female ; Humans ; Cardiovascular Diseases/epidemiology ; Atherosclerosis/epidemiology ; Risk Factors ; Biology ; Sex Factors
    Language English
    Publishing date 2023-10-07
    Publishing country Ireland
    Document type Editorial
    ZDB-ID 80061-2
    ISSN 1879-1484 ; 0021-9150
    ISSN (online) 1879-1484
    ISSN 0021-9150
    DOI 10.1016/j.atherosclerosis.2023.117297
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis.

    Lorey, Martina B / Öörni, Katariina / Kovanen, Petri T

    Frontiers in cardiovascular medicine

    2022  Volume 9, Page(s) 841545

    Abstract: Circulating apolipoprotein B-containing lipoproteins, notably the low-density lipoproteins, enter the inner layer of the arterial wall, the intima, where a fraction of them is retained and modified by proteases, lipases, and oxidizing agents and enzymes. ...

    Abstract Circulating apolipoprotein B-containing lipoproteins, notably the low-density lipoproteins, enter the inner layer of the arterial wall, the intima, where a fraction of them is retained and modified by proteases, lipases, and oxidizing agents and enzymes. The modified lipoproteins and various modification products, such as fatty acids, ceramides, lysophospholipids, and oxidized lipids induce inflammatory reactions in the macrophages and the covering endothelial cells, initiating an increased leukocyte diapedesis. Lipolysis of the lipoproteins also induces the formation of cholesterol crystals with strong proinflammatory properties. Modified and aggregated lipoproteins, cholesterol crystals, and lipoproteins isolated from human atherosclerotic lesions, all can activate macrophages and thereby induce the secretion of proinflammatory cytokines, chemokines, and enzymes. The extent of lipoprotein retention, modification, and aggregation have been shown to depend largely on differences in the composition of the circulating lipoprotein particles. These properties can be modified by pharmacological means, and thereby provide opportunities for clinical interventions regarding the prevention and treatment of atherosclerotic vascular diseases.
    Language English
    Publishing date 2022-03-03
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2781496-8
    ISSN 2297-055X
    ISSN 2297-055X
    DOI 10.3389/fcvm.2022.841545
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Aggregation Susceptibility of Low-Density Lipoproteins—A Novel Modifiable Biomarker of Cardiovascular Risk

    Katariina Öörni / Petri T. Kovanen

    Journal of Clinical Medicine, Vol 10, Iss 1769, p

    2021  Volume 1769

    Abstract: Circulating low-density lipoprotein (LDL) particles enter the arterial intima where they bind to the extracellular matrix and become modified by lipases, proteases, and oxidizing enzymes and agents. The modified LDL particles aggregate and fuse into ... ...

    Abstract Circulating low-density lipoprotein (LDL) particles enter the arterial intima where they bind to the extracellular matrix and become modified by lipases, proteases, and oxidizing enzymes and agents. The modified LDL particles aggregate and fuse into larger matrix-bound lipid droplets and, upon generation of unesterified cholesterol, cholesterol crystals are also formed. Uptake of the aggregated/fused particles and cholesterol crystals by macrophages and smooth muscle cells induces their inflammatory activation and conversion into foam cells. In this review, we summarize the causes and consequences of LDL aggregation and describe the development and applications of an assay capable of determining the susceptibility of isolated LDL particles to aggregate when exposed to human recombinant sphingomyelinase enzyme ex vivo. Significant person-to-person differences in the aggregation susceptibility of LDL particles were observed, and such individual differences largely depended on particle lipid composition. The presence of aggregation-prone LDL in the circulation predicted future cardiovascular events in patients with atherosclerotic cardiovascular disease. We also discuss means capable of reducing LDL particles’ aggregation susceptibility that could potentially inhibit LDL aggregation in the arterial wall. Whether reductions in LDL aggregation susceptibility are associated with attenuated atherogenesis and a reduced risk of atherosclerotic cardiovascular diseases remains to be studied.
    Keywords foam cell ; low-density lipoprotein ; LDL aggregation ; LDL retention ; lipid accumulation ; Medicine ; R
    Language English
    Publishing date 2021-04-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: High cholesterol absorption: A risk factor of atherosclerotic cardiovascular diseases?

    Simonen, Piia / Öörni, Katariina / Sinisalo, Juha / Strandberg, Timo E / Wester, Ingmar / Gylling, Helena

    Atherosclerosis

    2023  Volume 376, Page(s) 53–62

    Abstract: Lowering elevated low-density lipoprotein cholesterol (LDL-C) concentrations reduces the risk of atherosclerotic cardiovascular diseases (ASCVDs). However, increasing evidence suggests that cholesterol metabolism may also be involved in the risk ... ...

    Abstract Lowering elevated low-density lipoprotein cholesterol (LDL-C) concentrations reduces the risk of atherosclerotic cardiovascular diseases (ASCVDs). However, increasing evidence suggests that cholesterol metabolism may also be involved in the risk reduction of ASCVD events. In this review, we discuss if the different profiles of cholesterol metabolism, with a focus on high cholesterol absorption, are atherogenic, and what could be the possible mechanisms. The potential associations of cholesterol metabolism and the risk of ASCVDs are evaluated from genetic, metabolic, and population-based studies and lipid-lowering interventions. According to these studies, loss-of-function genetic variations in the small intestinal sterol transporters ABCG5 and ABCG8 result in high cholesterol absorption associated with low cholesterol synthesis, low cholesterol elimination from the body, and a high risk of ASCVDs. In contrast, loss-of-function genetic variations in another intestinal sterol transporter, NPC1L1 result in low cholesterol absorption associated with high cholesterol synthesis, elevated cholesterol elimination from the body, and low risk of ASCVDs. Statin monotherapy is not sufficient to reduce the ASCVD risk in cases of high cholesterol absorption, and these individuals need combination therapy of statin with cholesterol absorption inhibition. High cholesterol absorption, i.e., >60%, is estimated to occur in approximately one third of a population, so taking it into consideration is important to optimise lipid-lowering therapy to prevent atherosclerosis and reduce the risk of ASCVD events.
    MeSH term(s) Humans ; Atherosclerosis/drug therapy ; Atherosclerosis/etiology ; Atherosclerosis/genetics ; Atherosclerosis/prevention & control ; ATP Binding Cassette Transporter, Subfamily G/genetics ; Cholesterol/metabolism ; Genetic Variation ; Hypercholesterolemia/complications ; Hypercholesterolemia/drug therapy ; Hypercholesterolemia/prevention & control ; Risk Factors ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Biomarkers/blood
    Chemical Substances ATP Binding Cassette Transporter, Subfamily G ; Cholesterol (97C5T2UQ7J) ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Biomarkers
    Language English
    Publishing date 2023-06-02
    Publishing country Ireland
    Document type Journal Article ; Review
    ZDB-ID 80061-2
    ISSN 1879-1484 ; 0021-9150
    ISSN (online) 1879-1484
    ISSN 0021-9150
    DOI 10.1016/j.atherosclerosis.2023.06.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Why and how increased plasma ceramides predict future cardiovascular events?

    Öörni, Katariina / Jauhiainen, Matti / Kovanen, Petri T

    Atherosclerosis

    2020  Volume 314, Page(s) 71–73

    MeSH term(s) Ceramides ; Coronary Artery Disease ; Humans ; Plasma ; Sphingomyelin Phosphodiesterase
    Chemical Substances Ceramides ; Sphingomyelin Phosphodiesterase (EC 3.1.4.12)
    Language English
    Publishing date 2020-10-09
    Publishing country Ireland
    Document type Editorial ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 80061-2
    ISSN 1879-1484 ; 0021-9150
    ISSN (online) 1879-1484
    ISSN 0021-9150
    DOI 10.1016/j.atherosclerosis.2020.09.030
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: OxLDL sensitizes platelets for increased formation of extracellular vesicles capable of finetuning macrophage gene expression.

    Maaninka, Katariina / Neuvonen, Maarit / Kerkelä, Erja / Hyvärinen, Kati / Palviainen, Mari / Kamali-Moghaddam, Masood / Federico, Antonio / Greco, Dario / Laitinen, Saara / Öörni, Katariina / Siljander, Pia Rm

    European journal of cell biology

    2023  Volume 102, Issue 2, Page(s) 151311

    Abstract: Platelet extracellular vesicles (PEVs) generated upon platelet activation may play a role in inflammatory pathologies such as atherosclerosis. Oxidized low-density lipoprotein (oxLDL), a well-known contributor to atherogenesis, activates platelets and ... ...

    Abstract Platelet extracellular vesicles (PEVs) generated upon platelet activation may play a role in inflammatory pathologies such as atherosclerosis. Oxidized low-density lipoprotein (oxLDL), a well-known contributor to atherogenesis, activates platelets and presensitizes them for activation by other agonists. We studied the effect of oxLDL on the secretion, composition, and inflammatory functions of PEVs using contemporary EV analytics. Platelets were activated by co-stimulation with thrombin (T) and collagen (C) ± oxLDL and characterized by high-resolution flow cytometry, nanoparticle tracking analysis, proximity extension assay, western blot, and electron microscopy. The effect of PEVs on macrophage differentiation and functionality was examined by analyzing macrophage surface markers, cytokine secretion, and transcriptome. OxLDL upregulated TC-induced formation of CD61
    MeSH term(s) Blood Platelets/metabolism ; Macrophages/metabolism ; Lipoproteins, LDL/pharmacology ; Lipoproteins, LDL/metabolism ; Extracellular Vesicles/metabolism ; Gene Expression
    Chemical Substances oxidized low density lipoprotein ; Lipoproteins, LDL
    Language English
    Publishing date 2023-03-15
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 391967-5
    ISSN 1618-1298 ; 0070-2463 ; 0171-9335
    ISSN (online) 1618-1298
    ISSN 0070-2463 ; 0171-9335
    DOI 10.1016/j.ejcb.2023.151311
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Neutrophil proteinase 3 - An LDL- and HDL-proteolyzing enzyme with a potential to contribute to cholesterol accumulation in human atherosclerotic lesions.

    Nguyen, Su Duy / Maaninka, Katariina / Mäyränpää, Mikko I / Baumann, Marc / Soliymani, Rabah / Lee-Rueckert, Miriam / Jauhiainen, Matti / Kovanen, Petri T / Öörni, Katariina

    Biochimica et biophysica acta. Molecular and cell biology of lipids

    2022  Volume 1867, Issue 12, Page(s) 159225

    MeSH term(s) Atherosclerosis/pathology ; Cholesterol ; Humans ; Myeloblastin
    Chemical Substances Cholesterol (97C5T2UQ7J) ; Myeloblastin (EC 3.4.21.76)
    Language English
    Publishing date 2022-09-02
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 60-7
    ISSN 1879-2618 ; 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2650 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    ISSN (online) 1879-2618 ; 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2650
    ISSN 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    DOI 10.1016/j.bbalip.2022.159225
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Fatty fish consumption reduces lipophilic index in erythrocyte membranes and serum phospholipids.

    Lyytinen, Arja T / Yesmean, Monira / Manninen, Suvi / Lankinen, Maria / Bhalke, Monika / Fredrikson, Linda / Käkelä, Reijo T / Öörni, Katariina / Schwab, Ursula S

    Nutrition, metabolism, and cardiovascular diseases : NMCD

    2023  Volume 33, Issue 7, Page(s) 1453–1460

    Abstract: Background and aims: Lipophilic index (LI) has been introduced to assess the overall fatty acid lipophilicity and as a simple estimate of membrane fluidity. However, little is known on effect of diet on LI. We tested if Camelina sativa oil (CSO) high in ...

    Abstract Background and aims: Lipophilic index (LI) has been introduced to assess the overall fatty acid lipophilicity and as a simple estimate of membrane fluidity. However, little is known on effect of diet on LI. We tested if Camelina sativa oil (CSO) high in ALA, fatty fish (FF) or lean fish (LF) affect LI as compared to control diet and, secondarily, if the LI is associated with HDL lipids and functionality and LDL lipidome.
    Methods and results: We used data from two randomized clinical trials. The AlfaFish intervention lasted 12 weeks and 79 subjects with impaired glucose tolerance were randomized to FF, LF, CSO or control group. In the Fish trial, 33 subjects with myocardial infarction or unstable ischemic heart attack were randomized to FF, LF or control group for 8 weeks. LI was calculated from erythrocyte membrane fatty acids in AlfaFish and from serum phospholipids in Fish trial. HDL lipids were measured using high-throughput proton nuclear magnetic resonance spectroscopy. There was a significant decrease in LI in the FF group in the AlfaFish (fold change 0.98 ± 0.03) and in the Fish trial (0.95 ± 0.04) and the decrease differed from that of control group in both trials and from CSO group in the AlfaFish study. There were no significant changes in LI in LF or CSO groups. The mean diameter of HDL particles and concentration of large HDL particles were inversely associated with LI.
    Conclusion: FF consumption decreased LI indicating better membrane fluidity in subjects with impaired glucose tolerance or coronary heart disease.
    MeSH term(s) Animals ; Phospholipids ; Glucose Intolerance ; Erythrocyte Membrane ; Coronary Disease ; Seafood ; Fatty Acids ; Myocardial Infarction ; Fish Oils
    Chemical Substances Phospholipids ; Fatty Acids ; Fish Oils
    Language English
    Publishing date 2023-04-17
    Publishing country Netherlands
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 1067704-5
    ISSN 1590-3729 ; 0939-4753
    ISSN (online) 1590-3729
    ISSN 0939-4753
    DOI 10.1016/j.numecd.2023.04.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top